caffeic acid phenethyl ester has been researched along with wogonin in 2 studies
| Studies (caffeic acid phenethyl ester) | Trials (caffeic acid phenethyl ester) | Recent Studies (post-2010) (caffeic acid phenethyl ester) | Studies (wogonin) | Trials (wogonin) | Recent Studies (post-2010) (wogonin) |
|---|---|---|---|---|---|
| 840 | 1 | 469 | 492 | 0 | 320 |
| Protein | Taxonomy | caffeic acid phenethyl ester (IC50) | wogonin (IC50) |
|---|---|---|---|
| Lysine-specific histone demethylase 1A | Homo sapiens (human) | 8.87 | |
| Cyclin-T1 | Homo sapiens (human) | 0.1927 | |
| Pyruvate kinase PKM | Homo sapiens (human) | 2.01 | |
| Cyclin-A2 | Homo sapiens (human) | 1.46 | |
| Cyclin-C | Homo sapiens (human) | 5.9 | |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | 1.46 | |
| Nitric oxide synthase, inducible | Mus musculus (house mouse) | 7.8 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 1.46 | |
| Cyclin-dependent kinase 8 | Homo sapiens (human) | 5.9 | |
| Cyclin-dependent kinase 9 | Homo sapiens (human) | 0.192 | |
| Prostaglandin G/H synthase 2 | Mus musculus (house mouse) | 1.07 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Backlund, A; Bohlin, L; Gottfries, J; Larsson, J | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
2 other study(ies) available for caffeic acid phenethyl ester and wogonin
| Article | Year |
|---|---|
Expanding the ChemGPS chemical space with natural products.
Topics: Biological Products; Combinatorial Chemistry Techniques; Computer Graphics; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Evaluation, Preclinical; Molecular Structure; Prostaglandin-Endoperoxide Synthases; Structure-Activity Relationship | 2005 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |